Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson L Michael

Showing results (261-270 of 372) with videos related to

Pageof 38
Sort By:
Science (New York, N.Y.)|January 6, 2018
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2020
HLA tapasin independence: broader peptide repertoire and HIV controlArman A Bashirova, Mathias Viard, Vivek Naranbhai, et al.
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Science Translational Medicine|December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeysPeter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular CytotoxicityProssy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Journal of Infectious Diseases|July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Pageof 38

Showing results (261-270 of 372) with videos related to

Sort By:
Pageof 38
Science (New York, N.Y.)|January 6, 2018
Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cellsVeron Ramsuran, Vivek Naranbhai, Amir Horowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2020
HLA tapasin independence: broader peptide repertoire and HIV controlArman A Bashirova, Mathias Viard, Vivek Naranbhai, et al.
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2021
Preferential and persistent impact of acute HIV-1 infection on CD4<sup>+</sup> iNKT cells in colonic mucosaDominic Paquin-Proulx, Kerri G Lal, Yuwadee Phuang-Ngern, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Science Translational Medicine|December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeysPeter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2019
Terminal Effector CD8 T Cells Defined by an IKZF2<sup>+</sup>IL-7R<sup>-</sup> Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular CytotoxicityProssy Naluyima, Kerri G Lal, Margaret C Costanzo, et al.
The Journal of Infectious Diseases|July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Pageof 38